+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hypovolemia Drug"

From
Hypovolemia - Epidemiology Forecast - 2032 - Product Thumbnail Image

Hypovolemia - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hypovolemia - Pipeline Insight, 2024 - Product Thumbnail Image

Hypovolemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Hypovolemia is a condition in which the body has an abnormally low volume of blood. It is a common complication of cardiovascular diseases, and is often treated with drugs. Cardiovascular drugs used to treat hypovolemia include diuretics, vasopressors, and inotropes. Diuretics are used to reduce fluid retention, while vasopressors and inotropes are used to increase blood pressure and cardiac output. Other drugs used to treat hypovolemia include anticoagulants, antiarrhythmics, and antithrombotics. The hypovolemia drug market is a rapidly growing segment of the cardiovascular drug market. It is driven by the increasing prevalence of cardiovascular diseases, as well as the development of new drugs to treat hypovolemia. Companies in the hypovolemia drug market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. Show Less Read more